188 related articles for article (PubMed ID: 28423648)
1. Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer.
Ntantie E; Fletcher J; Amissah F; Salako OO; Nkembo AT; Poku RA; Ikpatt FO; Lamango NS
Oncotarget; 2017 May; 8(19):31726-31744. PubMed ID: 28423648
[TBL] [Abstract][Full Text] [Related]
2. Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines.
Tawfeeq N; Lazarte JMS; Jin Y; Gregory MD; Lamango NS
Oncotarget; 2023 Mar; 14():243-257. PubMed ID: 36961909
[TBL] [Abstract][Full Text] [Related]
3. Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer Cells.
Nkembo AT; Amissah F; Ntantie E; Poku RA; Salako OO; Ikpatt OF; Lamango NS
Curr Cancer Drug Targets; 2019; 19(10):838-851. PubMed ID: 30914025
[TBL] [Abstract][Full Text] [Related]
4. Suppression of focal adhesion formation may account for the suppression of cell migration, invasion and growth of non-small cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitors.
Ntantie E; Allen MJ; Fletcher J; Nkembo AT; Lamango NS; Ikpatt OF
Oncotarget; 2018 May; 9(40):25781-25795. PubMed ID: 29899821
[TBL] [Abstract][Full Text] [Related]
5. Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling.
Lamango NS; Nkembo AT; Ntantie E; Tawfeeq N
Curr Med Chem; 2021; 28(18):3476-3489. PubMed ID: 33176634
[TBL] [Abstract][Full Text] [Related]
6. Polyisoprenylated cysteinyl amide inhibitors induce caspase 3/7- and 8-mediated apoptosis and inhibit migration and invasion of metastatic prostate cancer cells.
Poku RA; Salako OO; Amissah F; Nkembo AT; Ntantie E; Lamango NS
Am J Cancer Res; 2017; 7(7):1515-1527. PubMed ID: 28744401
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
8. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells.
El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM
Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075
[TBL] [Abstract][Full Text] [Related]
9. Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl Amide Inhibitors Causes Apoptosis and Disrupts Breast Cancer Cell Invasion.
Lazarte JMS; Lamango NS
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540084
[TBL] [Abstract][Full Text] [Related]
10. Disruption of actin filaments and suppression of pancreatic cancer cell viability and migration following treatment with polyisoprenylated cysteinyl amides.
Nkembo AT; Salako O; Poku RA; Amissah F; Ntantie E; Flores-Rozas H; Lamango NS
Am J Cancer Res; 2016; 6(11):2532-2546. PubMed ID: 27904769
[TBL] [Abstract][Full Text] [Related]
11. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
Edlund S; Landström M; Heldin CH; Aspenström P
Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
[TBL] [Abstract][Full Text] [Related]
13. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
14. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors.
Tawfeeq N; Jin Y; Lamango NS
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830912
[TBL] [Abstract][Full Text] [Related]
16. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
[TBL] [Abstract][Full Text] [Related]
17. Actin bundling by dynamin 2 and cortactin is implicated in cell migration by stabilizing filopodia in human non-small cell lung carcinoma cells.
Yamada H; Takeda T; Michiue H; Abe T; Takei K
Int J Oncol; 2016 Sep; 49(3):877-86. PubMed ID: 27572123
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs.
Chen QY; Xu LQ; Jiao DM; Yao QH; Wang YY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ
Int J Mol Med; 2011 Nov; 28(5):769-76. PubMed ID: 21837360
[TBL] [Abstract][Full Text] [Related]
19. Rho and Rac but not Cdc42 regulate endothelial cell permeability.
Wójciak-Stothard B; Potempa S; Eichholtz T; Ridley AJ
J Cell Sci; 2001 Apr; 114(Pt 7):1343-55. PubMed ID: 11257000
[TBL] [Abstract][Full Text] [Related]
20. Spatio-temporal co-ordination of RhoA, Rac1 and Cdc42 activation during prototypical edge protrusion and retraction dynamics.
Martin K; Reimann A; Fritz RD; Ryu H; Jeon NL; Pertz O
Sci Rep; 2016 Feb; 6():21901. PubMed ID: 26912264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]